Key result
Pacemapping using orthogonal surface ECG leads predicted the site of earliest breakthrough during ventricular tachycardia exactly in 22% of cases and within 1 cm in an additional 66% of cases.
Why the study?
Does pacemapping using orthogonal surface ECG leads accurately predict the site of earliest breakthrough of ventricular tachycardia in a canine model of myocardial infarction?
Does pacemapping using orthogonal surface ECG leads accurately predict the site of earliest breakthrough of ventricular tachycardia in a canine model of myocardial infarction?
Pacemapping using orthogonal surface ECG leads can predict the site of earliest breakthrough during ventricular tachycardia with a 1-cm resolution in the majority of cases in a canine model.
Supports ECG pacemapping refinement in infarct models; leaves open clinical translation pending human studies.
BACKGROUND: The precision and limitations of ventricular pacemapping as a method to localize the site of earliest breakthrough of ventricular tachycardia (VT) were investigated in a canine model of experimental myocardial infarction. METHODS AND RESULTS: Forty-one episodes of VT induced in 10 animals were mapped using a standard grid of 64 endocardial and epicardial bipolar electrodes to determine the site of earliest endocardial or epicardial breakthrough of activation during VT. Each of these 64 recording sites was also used for ventricular pacing during sinus rhythm at cycle lengths comparable to those of the VTs. Orthogonal X, Y, and Z Frank electrocardiographic (ECG) leads were recorded during all episodes of VT and ventricular pacing from all sites after the chest was closed in all animals. Surface ECG waveforms corresponding to each VT and each ventricular pacing were compared pairwise by measuring the Euclidean metric difference between the VT and ventricular pacing vectors with the orthogonal ECG leads as their X, Y, and Z components. The pacing site that generated the vector most similar to VT vector (smallest vectorial difference) was defined as the predicted breakthrough site. This predicted site of breakthrough was identical to the actual site of breakthrough determined by activation sequence mapping during VT for only nine VTs (22%). However, for an additional 27 VTs (66%), the observed and predicted breakthrough locations were at adjacent (1 cm or less apart) recording sites. For five VTs (12%), the two sites were remote, the distance between them exceeding 1 cm. CONCLUSIONS: In this model, locating the breakthrough site by pacemapping is exact in only a small minority of VTs. However, when orthogonal surface ECG leads are used for comparison, pacemapping can predict the site of earliest breakthrough during VT with a 1-cm resolution in the majority of VTs.
No takes yet. Share an insight, caveat, or question.
Lin et al. (1991) studied Ventricular tachycardia in experimental myocardial infarction (n=10). Ventricular pacemapping using orthogonal surface ECG leads vs. Activation sequence mapping was evaluated on Accuracy of predicted breakthrough site compared to actual site of breakthrough. Pacemapping using orthogonal surface ECG leads predicted the site of earliest breakthrough during ventricular tachycardia exactly in 22% of cases and within 1 cm in an additional 66% of cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: